Back to
Assenagon Asset Management S.A.
MRNS19 quarters
Position history for
Assenagon Asset Management S.A.'s holdings in MARINUS PHARMACEUTICALS INC
As of its Q4 2024 13F, Assenagon Asset Management held 57,128 shares of MRNS (Marinus Pharmaceuticals), worth $30,569. Assenagon Asset Management's 13F filings listed MRNS from Q2 2022 to Q4 2024, 11 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.2M
Total Shares Change
-92,101
Quarter-by-Quarter History
Other major holders of MRNS: Avoro Capital Advisors LLC, BlackRock Finance, Inc., FRANKLIN TEMPLETON INC